ArticleActa ortopedica brasileira2026
PATIENTS WITH SOFT TISSUE SARCOMA AFTER TREATMENT BY NON ORTHOPEDIC ONCOLOGIC SURGEONS: EPIDEMIOLOGICAL PROFILE, STAGING, AND THERAPEUTIC CHALLENGES.
Article in Acta ortopedica brasileira, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: this study analyzed patients with soft tissue sarcoma treated by non-orthopedic oncologists, evaluating their epidemiological profile, staging, and therapeutic challenges. Method: an analytical study in the form of a retrospective cohort, conducted through a review of medical records of patients treated at the hospital from January 1, 2011, to December 31, 2021. Results: a total of 61 patients were included, mostly male (55.7%), with a mean age of 42.8 years. The most frequent histological subtypes were synovial sarcoma (29.5%) and undifferentiated pleomorphic sarcoma (21.3%), with a predominance of high-grade tumors (75.4%). The majority of cases (77%) underwent resection, but without proper planning, leading to high recurrence rates (77%) and metastases (49.2%), with the lungs being the primary metastatic site. The mortality rate was 47.5%, with an average time to death of 3.1 years. Conclusion: the findings highlight the need for early diagnosis, specialized treatment, and multidisciplinary management to optimize clinical outcomes for patients. The adoption of standardized protocols in referral centers may reduce inadequate interventions and improve survival and quality of life for patients with soft tissue sarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.